SKI Market

A+| A| A-|

Indian Indices

Sensex

74,833.50 224.52
( 0.30%)

Global Indices

Nasdaq

49,714.12 -67.45
(-0.14%)

Dow Jones

7,466.35 44.39
(0.60%)

Hang Seng

63,198.64 456.07
(0.73%)

Nikkei 225

10,300.99 35.67
(0.35%)

Forex

USD-INR

95.60 0.47
(0.49%)

EUR-INR

112.29 0.30
(0.26%)

GBP-INR

129.50 0.02
(0.02%)

JPY-INR

0.61 0.00
(0.19%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

91669

INE0PLZ01012

36.3585943

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNREST

16.31

32.61

EPS(TTM)

Face Value()

Div & Yield %

2.33

Back

CEAT consolidated net profit rises 60.41% in the December 2025 quarter

Jan 20,2026

Net profit of CEAT rose 60.41% to Rs 155.77 crore in the quarter ended December 2025 as against Rs 97.11 crore during the previous quarter ended December 2024. Sales rose 25.98% to Rs 4157.05 crore in the quarter ended December 2025 as against Rs 3299.90 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	4157.05	3299.90	26
OPM %	13.55	10.33	-
PBDT	464.44	269.24	73
PBT	276.30	127.75	116
NP	155.77	97.11	60

74,833.50 224.52 ( 0.30%)

49,714.12 -67.45 (-0.14%)

7,466.35 44.39 (0.60%)

63,198.64 456.07 (0.73%)

10,300.99 35.67 (0.35%)

95.60 0.47 (0.49%)

112.29 0.30 (0.26%)

129.50 0.02 (0.02%)

0.61 0.00 (0.19%)